Clinical value of R-spondins in triple-negative and metaplastic breast cancers

Florence Coussy(Institut Curie), Ivan Bièche(Délégation Paris 5)

British Journal of Cancer

May 4, 2017

10.1038/bjc.2017.131

Cited by 39

Related Papers

Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers

|Journal of Hematology & Oncology|2020|54

<i>MED12</i> mutations in breast phyllodes tumors: evidence of temporal tumoral heterogeneity and identification of associated critical signaling pathways

|Oncotarget|2016|34